Clinical Trials Arena December 5, 2024
The uncertainty and fears following the US Supreme Court’s decision to overturn Roe versus Wade have been heightened following Donald Trump’s election win.
It has been over two years since the US Supreme Court’s decision in Dobbs versus Jackson Women’s Health to overturn the constitutional protection for abortion that had previously been established as a result of the 1973 Roe versus Wade decision.
While most of the focus has been on the direct consequences of the abortion restrictions, namely maternal morbidity, and mortality, these restrictions have ethical, legal, and practical implications for everyone involved in clinical trials.
The recent US elections and the upcoming Donald Trump administration have only increased the topic’s uncertainty. Allison Whelan, assistant professor at the Georgia...
Today's Sponsors
Today's Sponsor